Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
RET inhib
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Caprelsa
(vandetanib) / Sanofi
Retevmo
(selpercatinib) / Eli Lilly
motesanib
(AMG 706) / Takeda
Balversa
(erdafitinib) / J&J
Iclusig
(ponatinib) / Takeda, Otsuka
sitravatinib
(MGCD516) / BeiGene
